Vivimed Labs Limited has submitted a regulatory disclosure to BSE Limited and National Stock Exchange of India Ltd regarding the status of re-lodgement requests for physical share transfers.
The disclosure is made in compliance with SEBI Circular No. SEBI/HO/38/13/11(2)2026-MIRSD-POD/1/3750/2026 dated January 30, 2026, which mandates reporting on the special window for re-lodgement of physical share transfer requests.
The company has enclosed a report dated July 06, 2026, received from its Registrar and Share Transfer Agent, Aarthi Consultants Pvt Ltd, detailing the status as of June 2026.
Status Report Details (June 2026):
- Number of requests received during the month: NIL
- Number of requests processed during the month: NIL
- Number of requests approved during the month: NIL
- Number of requests rejected during the month: NIL
- Average time taken for processing of requests: NA (not applicable)
The report confirms that no shareholders utilized the special window for re-lodgement of physical share transfer requests during June 2026.
Entities Involved:
- Registrar and Share Transfer Agent: Aarthi Consultants Private Limited (SEBI Regn. No. INR000000379)
- Signatory from Vivimed Labs: Yugandhar Kopparthi, Company Secretary
- Signatory from Aarthi Consultants: Jagan Mohan Gobburi, Compliance Officer
Financial Impact:
No financial impact disclosed. The notification is purely procedural regarding share transfer administration.
Capital Structure Impact:
No impact on capital structure reported. The nil activity indicates no changes to shareholding patterns through this mechanism during the reporting period.